Page last updated: 2024-10-28

hydroxychloroquine and Ulcer

hydroxychloroquine has been researched along with Ulcer in 3 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Ulcer: A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.

Research Excerpts

ExcerptRelevanceReference
"Lipodystrophy was seen in 10/33 (30."1.33Twelve years experience of juvenile dermatomyositis in North India. ( Bansal, A; Singh, S, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bellan, M1
Parisi, S1
Stobbione, P1
Pedrinelli, AR1
Rizzi, E1
Casciaro, GF1
Vassia, V1
Landi, R1
Cittone, MG1
Rigamonti, C1
Patrucco, F1
Ditto, MC1
Finucci, A1
Realmuto, C1
Todoerti, M1
Parodi, M1
Rossi, P1
Pirisi, M1
Fusaro, E1
Sainaghi, PP1
Masatlioğlu, SP1
Göktay, F1
Mansur, AT1
Akkaya, AD1
Güneş, P1
Singh, S1
Bansal, A1

Other Studies

3 other studies available for hydroxychloroquine and Ulcer

ArticleYear
Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients.
    Scandinavian journal of rheumatology, 2020, Volume: 49, Issue:6

    Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Cohort Studies; COVID-19; Female; Humans; Hydroxychlo

2020
Systemic lupus erythematosus presenting as pyoderma gangrenosum in two cases.
    Rheumatology international, 2009, Volume: 29, Issue:7

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Antiphospholipi

2009
Twelve years experience of juvenile dermatomyositis in North India.
    Rheumatology international, 2006, Volume: 26, Issue:6

    Topics: Adolescent; Age of Onset; Azathioprine; Calcinosis; Child; Child, Preschool; Deglutition Disorders;

2006